Just days after Johnson & Johnson revealed that it plans to shut down its 410-worker Animas insulin pump subsidiary, Insulet said it would offer existing Animas insulin pump users a free trial of the company’s Omnipod system.
Insulet’s Welcome Program includes a free Omnipod tubeless insulin delivery system, built-in blood glucose meter and 30 days of supplies at not cost to the user.
“We are offering this program to help ensure people with diabetes have a choice when it comes to their treatment options,” chief commercial officer Bret Christensen said in prepared remarks.
